Depletion of Methionine Aminopeptidase 2 Does Not Alter Cell Response to Fumagillin or Bengamides

Cancer Research

Volumn 64, Issue 9, 2004, Pages 2984-2987

  Kim, Sunkyu ^a   LaMontagne, Kenneth ^a   Sabio, Michael ^a   Sharma, Sushil ^a   Versace, Richard W ^a   Yusuff, Naeem ^a   Phillips, Penny E ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BENGAMIDE DERIVATIVE; FUMAGILLIN; LAF 389; LBM 648; METHIONYL AMINOPEPTIDASE; METHIONYL AMINOPEPTIDASE 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; ENDOTHELIUM CELL; GROWTH REGULATION; HUMAN; HUMAN CELL; IC 50; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

AMINOPEPTIDASES; AZEPINES; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CELL LINE, TUMOR; CYCLOHEXANES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FATTY ACIDS, UNSATURATED; HUMANS; LUNG NEOPLASMS; METALLOENDOPEPTIDASES; RNA, SMALL INTERFERING; SESQUITERPENES; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 2342640861     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0019     Document Type: Article

References (17)

1. Lowther WT, Matthews BW. Structure and function of the methionine aminopeptidases. Biochim Biophys Acta 2000;1477:157-67.
2. 67). Biochim Biophys Acta 1995;1260:333-6.
3. 67) is a methionine aminopeptidase. Biochem Biophys Res Comm 1996;227:152-9.
4. Nagase T, Miyajima N, Tanaka A, et al. Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res 1995;2:37-43.
5. Ingber D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Lond.) 1990;348:555-7.
6. Sin N, Meng L, Wang MQW, Wen JJ, Bornmann WG, Crews CM. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci USA 1997;94:6099-103.
7. Griffith EC, Su Z, Turk BE, et al. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol 1997;4:461-71.
8. Kruger EA, Figg WD. TNP-470: an angiogenesis inhibitor in clinical development for cancer. Exp Opin Investig Drugs 2000;9:1383-96.
9. Logothetis CJ, Wu KK, Finn LD, et al. Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. Clin Cancer Res 2001;7:1198-203.
10. Towbin H, Bair KW, DeCaprio JA, et al. Proteomics based target identification: Bengamides as a new class of methionine aminopeptidase inhibitors. J Biol Chem 2003;278:52964-71.
11. Clark TJ. Part I. Total synthesis of bengamide z. Part II. Studies toward asymmetric acylation of α-oxygenated imides. (2001), 225 pp. CAN 137:278990 AN 2002: 750153 CAPLUS.
12. Kinder FR, Versace RW, Bair KB, et al. Synthesis and antitumor activity of ester-modified analogues of bengamide B. J Med Chem 2001;44:3692-9.
13. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond.) 2001;411:494-8.
14. Griffith EC, Su Z, Niwayama S, Ramsay CA, Chang Y-H, Liu JO. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc Natl Acad Sci USA 1998;95:15183-8.
15. Liu S, Widom J, Kemp CW, Crews CM, Clardy J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science (Wash. DC) 1998;282;1324-7.
16. Serero A, Giglione C, Sardini A, Martinez-Sanz J, Meinnel T. An unusual peptide deformylase features in the human mitochondrial N-terminal methionine excision pathway. J Biol Chem 2003;278:52953-63.
17. Lazarus DD, Bernier SG, Labenski MT, et al. Inhibition of primary tumor growth by PPI-2458, a methionine aminopeptidase-2 inhibitor: dose and schedule responses. AACR-EORTC International Conference, abstract no. A174 2003.